Detransition lawsuits in the US are real, but a filed lawsuit is not a proven case. Personal regret does not equal clinical negligence, and the claim that clinics routinely skipped informed consent is not yet supported by decided judgments. The legal and medical picture is genuinely more complicated than the headlines suggest.
What is actually being claimed in these lawsuits?
Over the past few years, a number of people who have detransitioned have filed legal claims against the clinicians and clinics who provided their gender-affirming care. Most of the claims centre on informed consent: the allegation that the risks of treatment, including the possibility that a patient might later regret it, were not adequately explained before care began. Some also allege that psychological or psychiatric evaluation was insufficient, or that a patient's other mental health needs were not properly accounted for.
Those are serious allegations, and they deserve to be taken seriously. If a clinician genuinely failed to explain material risks, or proceeded with care that was not appropriate for a particular patient, that is a legitimate concern for the legal system to examine. The right response to a real failure is accountability, not dismissal.
But a lawsuit is the beginning of a legal process, not its conclusion. The fact that cases have been filed tells us that people are aggrieved and have found lawyers. It does not tell us that the care they received was negligent. That determination belongs to courts, and the courts have not yet decided most of these cases.
What does informed consent actually mean in clinical practice?
Informed consent is not a signature on a form. It is a process: a conversation, sometimes many conversations, in which a clinician explains what a treatment involves, what the risks and benefits are, what the alternatives are, and what happens if the person chooses not to proceed. The person receiving care must be able to take that information in, weigh it, and make a voluntary decision.
In gender-affirming care, this process has typically been thorough, often painstakingly so. The established international standards, including those set out in the WPATH Standards of Care 8, have always required that patients receive clear information about the effects of hormone therapy, the possibility that some changes are irreversible, the impact on fertility, and the evidence base for the treatment they are considering. Many people who accessed gender-affirming care describe going through multiple assessments and lengthy waits before treatment was offered, not a rush through a form.
That does not mean every clinic in every context got it right. Informed consent can fail in practice even when the standards exist on paper. A conversation can be hurried, information can be incomplete, a clinician can misjudge a patient's capacity to process what they are being told. Those failures, when they happen, are real and they matter. But the question is whether they were widespread and systematic, and the lawsuits as filed do not answer that question.
Is regret the same as negligence?
This is the distinction that the coverage most often collapses. Regret is a real human experience. Some people who transitioned, whether medically or socially or both, later feel that it was not right for them, and detransition. That deserves acknowledgment without judgment. The experience of regret is not a failure of character, and detransitioned people are owed the same respect and care as anyone else.
But regret is not the same as clinical negligence in law or in medicine. A person can receive fully informed, competent, carefully delivered care and still arrive, years later, at a different understanding of themselves. Life changes people. Identity is not always linear. Transition, including detransition, is not always linear either, and I say that without any suggestion that detransition is a failure. It is part of the range of human experience.
For a legal claim to succeed on negligence grounds, the claimant must show not only that they were harmed, but that the harm resulted from a breach of the standard of care that a competent clinician would have met. Feeling differently about a decision years later does not, by itself, satisfy that test. The courts will have to determine, case by case, what each clinician actually said, what information was given, what the patient understood, and whether the care departed from accepted standards.
Why is this being framed as evidence of systematic failure?
The lawsuits have attracted significant political attention, particularly in the United States, where they have been taken up as evidence that gender-affirming care is inherently harmful and that clinicians have been reckless. Some of that framing comes from advocacy groups that oppose gender-affirming care altogether; some of it comes from media coverage that treats a filed claim as a finding of fact.
It is worth noticing the structure of that argument. If litigation proves that care was negligent, then we would have to conclude the same from the lawsuits brought against clinicians who refused to provide gender-affirming care, who misgendered patients, or whose gatekeeping caused documented harm. Lawsuits can be filed by anyone with a grievance and a lawyer. They are evidence of grievance, not of wrongdoing.
The people filing these claims deserve a fair hearing. So do the clinicians named. So do the many thousands of people who received gender-affirming care, gave informed consent, and whose lives are better for it. All of those realities can coexist, and the honest position is to wait for the evidence rather than to treat the filing of a lawsuit as a verdict.
What about the people whose experiences prompted these cases?
Here is what I think matters most: the people at the centre of these cases are real, and their experiences deserve to be taken seriously on their own terms, not flattened into a political argument about gender-affirming care.
Some detransitioned people describe feeling that they were not fully heard, that their other struggles were not adequately understood, or that the care they received moved faster than they were ready for. Those accounts matter. They point to places where the model of care might need to be more attentive, more individuated, more genuinely responsive to the whole person. Good care is not a protocol applied uniformly; it is a relationship in which a person is actually seen.
At the same time, the existence of people who wish their care had been different does not tell us that the care provided to the much larger group who are living well was wrong. Medicine always contains both: people for whom a treatment was right, and people for whom it turned out not to be. That is true of antidepressants, of joint replacements, of cancer treatments. The answer is better individual assessment and genuine ongoing support, not the removal of care from everyone who might benefit.
What should actually change?
If the lawsuits reveal anything useful, it is this: informed consent is a process, not a form, and it needs to be genuinely ongoing. A person starting hormone therapy at twenty-two is not the same person at thirty-two, and the support available to them should reflect that. Clinicians providing gender-affirming care should be able to discuss the full range of possible futures, including detransition, without that discussion becoming a barrier to care for the people who need it.
That is a conversation worth having. It is not the same conversation as the one that says the lawsuits prove that gender-affirming care is dangerous and should be restricted or banned. Those are two very different arguments, and conflating them does not serve anyone: not detransitioned people, not trans people currently accessing care, and not the clinicians trying to do right by both.
The cases will be decided. Some may succeed; some will not. What will matter, when they are, is the specific evidence about what each patient was told and what each clinician did. That evidence does not yet exist in the public record. Until it does, "lawsuits filed" is not the same as "informed consent was absent," and treating it as though it were is not analysis. It is advocacy presented as reporting.
If there is a topic that you would like me to cover, just let Sammy know.
Dr Helen Webberley is a gender specialist, medical educator, and advocate. She is the founder of GenderGP and writes about gender diversity, trans healthcare, and the lives of trans people.
Comments